ARROWg+ard Blue CVC Kit The ARROWg+ard Blue CVCs are intended to… — Class II medical device recall Z-2337-2017
Terminated recall by Arrow International Inc, reported 2017-06-21, distributed nationwide. The Arrow CVC is indicated to provide short-term (<30 days) central venous access for treatment of diseases or
| Recall number | Z-2337-2017 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Arrow International Inc, Reading, PA, United States |
| Recall initiated | 2017-05-09 |
| Classified | 2017-06-12 |
| Reported by FDA | 2017-06-21 |
| Terminated | 2018-09-17 |
| Distributed | Nationwide (US) |
| Countries outside the US | CA |
Product
ARROWg+ard Blue CVC Kit The ARROWg+ard Blue CVCs are intended to permit venous access to the central circulation
Reason for recall
The Arrow CVC is indicated to provide short-term (<30 days) central venous access for treatment of diseases or conditions requiring central venous access including, but not limited to: -multiple infusions of fluids, medications, or chemotherapy -infusion of fluids that are hypertonic, hyperosmolar, or have divergent pH values -frequent blood sampling or blood/blood components infusions -infusion of incompatible medications -central venous pressure monitoring lack of usable peripheral IV sites -replacement of multiple peripheral sites for IV access
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-2337-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.